Drug
Fluorometholone
Fluorometholone is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_3
1
20%
Ph phase_4
1
20%
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
completed360%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
unknown
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
NCT05313828
unknownphase_4
Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy
NCT03747614
completedphase_2
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
NCT01448213
completednot_applicable
Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium
NCT01288404
completedphase_3
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
NCT00707421
Clinical Trials (5)
Showing 5 of 5 trials
NCT05313828
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
NCT03747614Phase 4
Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy
NCT01448213Phase 2
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
NCT01288404Not Applicable
Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium
NCT00707421Phase 3
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5